Article details
Lana Medical Co. announced shareholders will vote on a 3% cash dividend (SAR 0.03 per share) for 2025 during an ordinary general meeting on June 30. The proposed dividend totals SAR 1.62 million from the company's SAR 54 million capital, with a record date set for June 30, 2026, and payment scheduled for November 22, 2026. Shareholders registered with Edaa by the end of the second trading day following the meeting will be eligible.
This announcement reflects Lana's commitment to returning value to shareholders, which could positively influence investor confidence. A successful vote may attract income-focused investors seeking stable dividends, potentially boosting the stock's liquidity on Tadawul. However, the dividend depends on shareholder approval and the company's financial performance in 2025.
For Gulf investors, this decision aligns with broader trends of Saudi firms prioritizing shareholder returns amid economic diversification efforts. Traders should monitor the voting outcome and subsequent stock price reactions, particularly around the record date. The healthcare sector's performance in Saudi Arabia may also impact Lana's valuation if the dividend is approved.
